Industrial PhD Candidate: Cancer Immunotherapy

Philochem AG; Zürich; Vor Ort; CHF 60.000 - 80.000; Vollzeit

Benefits dieser Stelle

Industrial PhD program

Cutting-edge infrastructure

Mentoring from industry and academia

Opportunities to publish

Collaborative team

Zusammenfassung

Philochem AG in Zürich, Switzerland invites applications for an Industrial PhD Candidate in Cancer Immunotherapy. You will design, engineer and characterize next-generation bispecific antibodies, applying cloning, expression, and in vitro/in vivo assays to support preclinical development and translational potential.

The role offers an integrated academic-industry PhD path, cross-disciplinary collaboration, and opportunities to publish in peer-reviewed journals.

Qualifikationen

• Master’s degree in Immunology, Biotechnology, Pharmaceutical Sciences, or related field.
• Strong interest in cancer immunology, immunotherapy, and therapeutic antibody development.
• Hands-on experience in molecular cloning, cell culture, and protein biochemistry.
• In vivo experience is a plus.
• Familiarity with immune cell assays and flow cytometry is desirable.
• Excellent communication, scientific curiosity, and proactive mindset.
• Fluent in English (written and spoken).

Aufgaben

• Design and generate bispecific antibody constructs using molecular biology techniques
• Produce and purify antibody-based molecules in mammalian expression systems
• Test selected candidates in relevant in vivo models
• Analyze data and contribute to experimental planning and troubleshooting
• Present findings regularly within the project team and at scientific meetings
• Collaborate with internal experts and academic supervisors across disciplines
• Write and publish scientific articles in peer-reviewed journals

Kenntnisse

Molecular cloning

Cell culture

Protein biochemistry

Flow cytometry

Ausbildung

Master’s degree in Immunology, Biotechnology, Pharmaceutical Sciences, or related field

Jobbeschreibung

Philochem AG in Zürich, Switzerland invites applications for an Industrial PhD Candidate in Cancer Immunotherapy. You will design, engineer and characterize next-generation bispecific antibodies, applying cloning, expression, and in vitro/in vivo assays to support preclinical development and translational potential.

The role offers an integrated academic-industry PhD path, cross-disciplinary collaboration, and opportunities to publish in peer-reviewed journals.